| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |